Life360 Innovations Inc. Now Conducting a Post-Market Clinical Follow-Up Study in the Greater Toronto Area
Life 360 Innovations Inc. (Life360 Innovations) is conducting a post-market clinical follow-up study for their men’s urinary incontinence product, Contino®, for eligible participants in the GTA.
Contino® has been licensed by Health Canada after the completion of a five-year, multi-site Canadian clinical trial.
Contino® has been developed as an aid to assist men in dealing with urinary incontinence. The device is personally fitted to each individual by a healthcare professional and is then self-administered.
To participate in this study, eligible males must be over the age of 18 and have evidence of moderate to severe urinary incontinence. The trial lasts for one year and requires 6 visits to see the study doctor for study-related testing. Throughout the study, you will receive the Contino® device at no cost and you may be reimbursed for travel and parking expenses.